Home › Companies › Puma Biotechnology, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Puma Biotechnology, Inc.’s Form 8-K, filed 2026-06-16 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore Puma Biotechnology, Inc. in the interactive database Compare manager voting policies
These tallies are Puma Biotechnology, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Alan H. Auerbach | 37,130,678 | -- | -- | 785,624 | 6,064,713 | Majority: yes |
| Elect Director: Alessandra Cesano | 37,472,173 | -- | -- | 444,129 | 6,064,713 | Majority: yes |
| Elect Director: Allison Dorval | 37,447,432 | -- | -- | 468,870 | 6,064,713 | Majority: yes |
| Elect Director: Michael P. Miller | 37,220,974 | -- | -- | 695,328 | 6,064,713 | Majority: yes |
| Elect Director: Jay M. Moyes | 36,586,798 | -- | -- | 1,329,504 | 6,064,713 | Majority: yes |
| Elect Director: Adrian M. Senderowicz | 37,217,253 | -- | -- | 699,049 | 6,064,713 | Majority: yes |
| Elect Director: Brian Stuglik | 37,372,588 | -- | -- | 543,714 | 6,064,713 | Majority: yes |
| Elect Director: Troy E. Wilson | 32,546,955 | -- | -- | 5,369,347 | 6,064,713 | Majority: yes |
Source: Puma Biotechnology, Inc., Form 8-K, filed with the SEC on 2026-06-16 — read the filing on EDGAR.
Each item below shows how the 168 asset managers that disclosed a Puma Biotechnology, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Puma Biotechnology, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
80% fund support · no official result
The 164 asset managers below cast 80% of the shares they voted on this item FOR (20,264,455 for, 5,161,355 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,865,028 | 13 | 2 | 0 | For |
| American Century | 0 | 3,844,803 | 0 | 0 | Against |
| BlackRock | 2,012,311 | 33,339 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 1,438,583 | 0 | 0 | 0 | For |
| Fidelity | 1,141,432 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 995,010 | 0 | 0 | 0 | For |
| Renaissance | 850,983 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 652,517 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 633,398 | 7,800 | 0 | 0 | For |
| Dimensional | 613,066 | 0 | 0 | 0 | For |
| State Street | 586,480 | 4,747 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 571,300 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 563,500 | 0 | 0 | Against |
| Northern Trust | 542,282 | 2,038 | 0 | 0 | For |
| Russell Investments | 499,630 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 467,921 | 10 | 0 | 0 | For |
| Goldman Sachs | 463,189 | 0 | 0 | 0 | For |
| AQR | 380,200 | 0 | 0 | 0 | For |
| Federated Hermes | 352,998 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 308,643 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 304,501 | 0 | 0 | 0 | For |
| Prudential/PGIM | 270,664 | 0 | 0 | 0 | For |
| Charles Schwab | 230,830 | 0 | 0 | 0 | For |
| SEI | 225,805 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 208,618 | 0 | 0 | 0 | For |
Showing the 25 largest of 164 asset managers. See all 164 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% fund support · no official result
The 61 asset managers below cast 95% of the shares they voted on this item FOR (10,301,649 for, 581,603 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,552,094 | 3 | 0 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 563,500 | 0 | 0 | Against |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 35,023 | 18,100 | 0 | 0 | For |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 37,130,678 for, 785,624 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 73% for, 2% withheld (74% of the company cast a for/withheld vote).
The 61 asset managers below cast 48.9% of the shares they voted on this item FOR (5,318,074 for, 5,555,297 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,540,929 | 11,168 | 0 | 0 | For |
| American Century | 0 | 1,911,728 | 0 | 0 | Against |
| Fidelity | 135,217 | 857,972 | 0 | 0 | Against |
| BlackRock | 0 | 632,585 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 563,500 | 0 | 0 | Against |
| Dimensional | 0 | 435,728 | 0 | 0 | Against |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 289,160 | 0 | 0 | Against |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,100 | 21,001 | 0 | 0 | For |
| AQR | 0 | 118,280 | 0 | 0 | Against |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 0 | 80,724 | 0 | 0 | Against |
| JPMorgan | 0 | 77,640 | 0 | 0 | Against |
| Legg Mason | 0 | 57,748 | 9,881 | 0 | Against |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 61,280 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 61,255 | 0 | 0 | Against |
| Putnam | 0 | 58,246 | 0 | 0 | Against |
| TIAA | 0 | 55,922 | 0 | 0 | Against |
| Nationwide | 23,301 | 29,822 | 0 | 0 | Against |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Adrian M. Senderowicz”): 37,217,253 for, 699,049 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 73% for, 1% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,865,709 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,086 | 0 | 3,011 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 37,130,678 for, 785,624 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 73% for, 2% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,865,709 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,086 | 0 | 3,011 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Alessandra Cesano”): 37,472,173 for, 444,129 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 74% for, 0.9% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,880,541 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,552,096 | 0 | 1 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Allison Dorval”): 37,447,432 for, 468,870 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 74% for, 1.0% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,869,765 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,087 | 0 | 3,010 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Brian Stuglik”): 37,372,588 for, 543,714 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 73% for, 1% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,869,765 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,087 | 0 | 3,010 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Jay M. Moyes”): 36,586,798 for, 1,329,504 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 72% for, 3% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,660,441 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,547,635 | 0 | 4,462 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 207,872 | 0 | Abstain |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Michael P. Miller”): 37,220,974 for, 695,328 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 73% for, 1% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (10,865,710 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,087 | 0 | 3,010 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Troy E. Wilson”): 32,546,955 for, 5,369,347 withheld, per its Form 8-K filed 2026-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,899,456 outstanding shares: 64% for, 11% withheld (74% of the company cast a for/withheld vote).
The 60 asset managers below cast 100% of the shares they voted on this item FOR (8,987,508 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,547,628 | 0 | 4,469 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 632,585 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 289,160 | 0 | Abstain |
| Russell Investments | 0 | 0 | 248,058 | 0 | Abstain |
| EA Series Trust | 0 | 0 | 207,872 | 0 | Abstain |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,100 | 0 | 21,001 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 110,123 | 0 | Abstain |
| Equitable | 0 | 0 | 80,724 | 0 | Abstain |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 9,881 | 0 | 57,748 | 0 | Abstain |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 61,280 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 61,255 | 0 | Abstain |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 41,401 | 0 | 11,722 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (352,311 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLOBEFLEX CAPITAL L P | 349,651 | 0 | 0 | 0 | For |
| Westbourne Investment Advisors, Inc. | 2,112 | 0 | 0 | 0 | For |
| Triton Financial Group Inc | 548 | 0 | 0 | 0 | For |
Ranked by the number of Puma Biotechnology, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 50,899,456 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.59% |
| 2 | American Century | 7.55% |
| 3 | BlackRock | 4.02% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 2.83% |
| 5 | Fidelity | 2.24% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.95% |
| 7 | Renaissance | 1.67% |
| 8 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 1.28% |
| 9 | LSV ASSET MANAGEMENT | 1.26% |
| 10 | Dimensional | 1.20% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 7.46% | 13F |
| BlackRock | 7.07% | 13F |
| Renaissance Technologies | 3.82% | 13F |
| Millennium Management | 2.90% | 13F |
| Dimensional Fund Advisors | 2.82% | 13F |
| Geode Capital | 2.00% | 13F |
| State Street | 1.80% | 13F |
| AQR Capital | 1.57% | 13F |
| Goldman Sachs | 1.32% | 13F |
| Northern Trust | 1.26% | 13F |
Percentages above are of 50,899,456 shares outstanding, as reported by Puma Biotechnology, Inc. on its Form 10-Q dated 2026-05-04 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Puma Biotechnology, Inc.’s 10-Q dated 2026-05-04. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Puma Biotechnology, Inc.'s shareholder meeting held 2026-06-11, in the 2025-2026 proxy season, 168 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,018 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Puma Biotechnology, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED… — the reporting funds cast 80% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
Puma Biotechnology, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).